• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
Invest logo white

Invest Liverpool City Region

World Famous, Word Leading

  • Why the Liverpool City Region?
    • Life Sciences Innovation Zone
    • Freeport
  • Key Sectors
    • Advanced Manufacturing
    • Creative
    • Digital & Technology
    • Financial, Professional and Business
    • Health and Life Sciences
  • Capital and Real Estate Programme
    • Investment Guide
    • Partnership Opportunities
    • Annual Hospitality Conference
    • MIPIM
    • UKREiiF
  • Resources
    • News
    • Meet the Team
    • Support

Archives for October 2022

Picture1 1

Heath Park ‘Port Sunlight’ masterplan is submitted for planning approval

SOG Group has submitted a planning application to Halton Borough Council in the next step of their ground-breaking proposals to transform The Heath Business and Technical Park into ‘Heath Park’, a 21st century version of Port Sunlight. Heath Park evolved from a global competition challenging architects, designers, planners and forward thinkers to create a sustainable …

Read moreHeath Park ‘Port Sunlight’ masterplan is submitted for planning approval
Daresbury Proteins   LYVA Labs 1 scaled

LYVA Labs invests in emerging biotech business Daresbury Proteins

Continuing to move through a pipeline of health and life science investment, LYVA Labs, the Liverpool City Region’s innovation commercialisation organisation, has announced its latest investment in emerging biotech, Daresbury Proteins.   Continuing to move through a pipeline of health and life science investment, LYVA Labs, the Liverpool City Region’s innovation commercialisation organisation, has announced its …

Read moreLYVA Labs invests in emerging biotech business Daresbury Proteins
Research 1

Clatterbridge now part of prestigious Biomedical Research Centre

The Clatterbridge Cancer Centre has secured another high-profile status – this time in a collaboration with London’s Royal Marsden Hospital. After an exacting process, Clatterbridge has now become part of a Biomedical Research Centre (BRC) in its partnership with The Royal Marsden, one of the most prestigious cancer centres in the world. Achieving BRC status …

Read moreClatterbridge now part of prestigious Biomedical Research Centre
HPO vaccine image

Liverpool City Region wins Government status for Vaccine Discovery, Development, and Manufacturing.

The Department for International Trade and Growth Platform to showcase the Liverpool City Region’s life sciences expertise at this year’s World Vaccine Congress in Barcelona. Growth Platform, Liverpool City Regions Growth Company, and the Department for International Trade (DIT) have launched a new Vaccines Discovery, Development and Manufacture High Potential Opportunity (HPO) in recognition of …

Read moreLiverpool City Region wins Government status for Vaccine Discovery, Development, and Manufacturing.

No 1 Mann Island, Pier Head, Liverpool. L3 1BP

© 2026 Liverpool City Region Combined Authority. All rights reserved.

A powerfully good website by Agent.

Terms & Conditions Privacy Policy